NEW YORK (GenomeWeb) – Quidel reported after the close of the market Friday that it expects to report fourth quarter revenues of $52 million to $53 million.

The firm's preliminary revenues fall well short of the average Wall Street estimate of $63.1 million. This firm also missed analysts' average estimate for revenues in Q3, reporting sales of $49.3 million compared to analysts' expectations for revenues of $50.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.